Pendal Group LTD Hutchmed (China) LTD Transaction History

Pendal Group LTD

  • $12.2 Billion
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 30, 2019
SELL
$23.09 - $37.69 $361,935 - $590,790
-15,675 Closed
0 $0
Q3 2018

Nov 05, 2018
SELL
$26.55 - $34.38 $66,136 - $85,640
-2,491 Reduced 13.71%
15,675 $0
Q2 2018

Jul 18, 2018
BUY
$27.79 - $34.49 $34,181 - $42,422
1,230 Added 7.26%
18,166 $0
Q1 2018

May 08, 2018
BUY
$28.87 - $41.13 $488,942 - $696,577
16,936 New
16,936 $0

Others Institutions Holding HCM

# of Institutions
65
Shares Held
6.88M
Call Options Held
6.2K
Put Options Held
1.1K
View Full List

About HUTCHMED (China) Ltd

HCM Quotes by TradingView
  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $2.47B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Pendal Group LTD Portfolio

Follow Pendal Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email